Hutner Capital Management Inc Abb Vie Inc. Transaction History

Hutner Capital Management Inc

$201 Million
Q3 2024

A detailed history of Hutner Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Hutner Capital Management Inc holds 38,502 shares of ABBV stock, worth $6.82 Million. This represents 3.79% of its overall portfolio holdings.

Number of Shares

38,502

Previous 38,565 0.16%

Holding current value

$6.82 Million

Previous $6.61 Million 14.95%

% of portfolio

3.79%

Previous 3.63%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $10,321 - $12,557	-63 Reduced 0.16%	38,502 $7.6 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $77,395 - $90,380	-500 Reduced 1.28%	38,565 $6.61 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $1,118 - $1,274	7 Added 0.02%	39,065 $7.11 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $114,483 - $128,935	-832 Reduced 2.09%	39,058 $6.05 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $52,634 - $60,932	-394 Reduced 0.98%	39,890 $5.95 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $2,252 - $2,803	17 Added 0.04%	40,284 $5.43 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $12,291 - $14,155	85 Added 0.21%	40,267 $6.42 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $59,888 - $71,821	433 Added 1.09%	40,182 $6.5 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $12,213 - $14,007	91 Added 0.23%	39,749 $5.34 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $11,147 - $14,171	-81 Reduced 0.2%	39,658 $6.07 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $20,852 - $25,872	-158 Reduced 0.4%	39,739 $6.44 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $42,434 - $53,692	-395 Reduced 0.98%	39,897 $5.4 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $19,790 - $22,465	186 Added 0.46%	40,292 $4.35 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $71,227 - $79,351	-677 Reduced 1.66%	40,106 $4.52 Million
Q1 2021 May 18, 2021	BUY	$102.3 - $112.62 $243,780 - $268,373	2,383 Added 6.21%	40,783 $4.41 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $6,922 - $9,345	86 Added 0.22%	38,400 $4.12 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $366,406 - $430,039	4,265 Added 12.53%	38,314 $3.36 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $679,112 - $908,754	9,256 Added 37.33%	34,049 $3.34 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $16,770 - $25,425	-260 Reduced 1.04%	24,793 $1.89 Million
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $1.65 Million - $2.1 Million	-25,053 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $72,665 - $85,524	-942 Reduced 3.62%	25,053 $2.02 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $56,830 - $70,087	730 Added 2.89%	25,995 $2.4 Million
Q2 2018 Jul 06, 2018	SELL	$89.78 - $106.23 $46,685 - $55,239	-520 Reduced 2.02%	25,265 $2.34 Million
Q1 2018 Apr 06, 2018	SELL	$92.01 - $123.21 $4,600 - $6,160	-50 Reduced 0.19%	25,785 $2.44 Million
Q3 2017 Oct 30, 2017	BUY	$69.85 - $89.22 $1.8 Million - $2.3 Million	25,835	25,835 $2.3 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hutner Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hutner Capital Management Inc with notifications on news.

Account

Hutner Capital Management Inc Abb Vie Inc. Transaction History